Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

JoF, Free Full-Text

PDF) Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?

PDF] Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review - Margret I Moré, Yvan Vandenplas, 2018

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis

Use of Saccharomyces boulardii CNCM I‐745 as therapeutic strategy for prevention of nonsteroidal anti‐inflammatory drug‐induced intestinal injury - D'Antongiovanni - 2023 - British Journal of Pharmacology - Wiley Online Library

Clostridium difficile infection – sboulardii – CNCM i-745

Fermentation, Free Full-Text

JoF, Free Full-Text

Saccharomyces boulardii: Supporting gastrointestinal health

Saccharomyces boulardii: Supporting gastrointestinal health

Overview of S. cerevisiae CNCM I-3856 potential modes of action in ETEC

Use of Saccharomyces boulardii CNCM I‐745 as therapeutic strategy for prevention of nonsteroidal anti‐inflammatory drug‐induced intestinal injury - D'Antongiovanni - 2023 - British Journal of Pharmacology - Wiley Online Library

Demonstrated mechanism of Saccharomyces boulardii CNCM I-745 action

Isolation and Characteristics of Extracellular Vesicles Produced by Probiotics: Yeast Saccharomyces boulardii CNCM I-745 and Bacterium Streptococcus salivarius K12